Publicaciones (27) Publicaciones en las que ha participado algún/a investigador/a

2019

  1. Adoptive T-cell therapy with CD45RA-depleted donor in the treatment of cytomegalovirus disease in immunocompromised non-transplant patients

    Antiviral Therapy, Vol. 24, Núm. 4, pp. 313-319

  2. An integrative approach to inform optimal administration of OX40 agonist antibodies in patients with advanced solid tumors

    Clinical Cancer Research, Vol. 25, Núm. 22, pp. 6709-6720

  3. Assessing the impact of the addition of dendritic cell vaccination to neoadjuvant chemotherapy in breast cancer patients: A model-based characterization approach

    British Journal of Clinical Pharmacology, Vol. 85, Núm. 8, pp. 1670-1683

  4. Cytokines in clinical cancer immunotherapy

    British Journal of Cancer, Vol. 120, Núm. 1, pp. 6-15

  5. Daratumumab in combination with urelumab to potentiate anti-myeloma activity in lymphocyte-deficient mice reconstituted with human NK cells

    OncoImmunology, Vol. 8, Núm. 7

  6. Designing clinical studies for biomarker discovery: The design criteria

    Proteomic and Metabolomic Approaches to Biomarker Discovery (Elsevier), pp. 441-466

  7. Expression analysis and significance of PD-1, LAG-3, and TIM-3 in human non-small cell lung cancer using spatially resolved and multiparametric single-cell analysis

    Clinical Cancer Research, Vol. 25, Núm. 15, pp. 4663-4673

  8. Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3

    Cell, Vol. 176, Núm. 1-2, pp. 334-347.e12

  9. Flow cytometry for fast screening and automated risk assessment in systemic light-chain amyloidosis

    Leukemia, Vol. 33, Núm. 5, pp. 1256-1267

  10. For whom the cell tolls? Intratumoral treatment links innate and adaptive immunity

    Clinical Cancer Research, Vol. 25, Núm. 4, pp. 1127-1129

  11. Identification of mutations associated with acquired resistance to sunitinib in renal cell cancer

    International Journal of Cancer, Vol. 145, Núm. 7, pp. 1991-2001

  12. Immune desertic landscapes in hepatocellular carcinoma shaped by β-catenin activation

    Cancer Discovery, Vol. 9, Núm. 8, pp. 1003-1005

  13. Immune mechanisms mediating abscopal effects in radioimmunotherapy

    Pharmacology and Therapeutics, Vol. 196, pp. 195-203

  14. Immunotherapeutic effects of intratumoral nanoplexed poly I:C

    Journal for ImmunoTherapy of Cancer, Vol. 7, Núm. 1

  15. Immunotherapy in non-small cell lung cancer: Facts and hopes

    Clinical Cancer Research, Vol. 25, Núm. 15, pp. 4592-4602

  16. Impact of prophylactic TNF blockade in the dual PD-1 and CTLA-4 immunotherapy efficacy and toxicity

    Cell Stress, Vol. 3, Núm. 7, pp. 236-239

  17. Intratumor Adoptive Transfer of IL-12 mRNA Transiently Engineered Antitumor CD8+ T Cells

    Cancer cell, Vol. 36, Núm. 6, pp. 613-629

  18. Metabolic consequences of T-cell costimulation in anticancer immunity

    Cancer Immunology Research, Vol. 7, Núm. 10, pp. 1664-1669

  19. Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma

    Nature Medicine, Vol. 25, Núm. 3, pp. 470-476

  20. Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy

    Nature, Vol. 569, Núm. 7756, pp. 428-432